{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:25:17Z","timestamp":1789601117730,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/ja.2016.106","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T02:21:46Z","timestamp":1472610106000},"page":"41-44","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection"],"prefix":"10.1038","volume":"70","author":[{"given":"Ikuko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Kanasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetada","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Fujie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Sekimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"BFja2016106_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1086\/513943","volume":"26","author":"DW Denning","year":"1998","unstructured":"Denning, D. W. Invasive aspergillosis. Clin. Infect. Dis. 26, 781\u2013803, quiz 804-805 (1998).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2016106_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1086\/318133","volume":"31","author":"T Yeghen","year":"2000","unstructured":"Yeghen, T. et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin. Infect. Dis. 31, 859\u2013868 (2000).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2016106_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","volume":"102","author":"T Fukuda","year":"2003","unstructured":"Fukuda, T. et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 102, 827\u2013833 (2003).","journal-title":"Blood"},{"key":"BFja2016106_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht, R. et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347, 408\u2013415 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFja2016106_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1517\/17425250903463878","volume":"6","author":"GR Thompson 3rd","year":"2010","unstructured":"Thompson, G. R. 3rd & Lewis, J. S. 2nd Pharmacology and clinical use of voriconazole. Expert Opin. Drug Metabol. Toxicol. 6, 83\u201394 (2010).","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"BFja2016106_CR6","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.7164\/antibiotics.29.1346","volume":"29","author":"A Endo","year":"1976","unstructured":"Endo, A., Kuroda, M. & Tsujita, Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J. Antibiot. 29, 1346\u20131348 (1976).","journal-title":"J. Antibiot."},{"key":"BFja2016106_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","volume":"40","author":"T Kino","year":"1987","unstructured":"Kino, T. et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. 40, 1249\u20131255 (1987).","journal-title":"J. Antibiot."},{"key":"BFja2016106_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1128\/AAC.44.1.57-62.2000","volume":"44","author":"S Tawara","year":"2000","unstructured":"Tawara, S. et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob. Agents Chemother. 44, 57\u201362 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016106_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7164\/antibiotics.43.1","volume":"43","author":"T Iwamoto","year":"1990","unstructured":"Iwamoto, T. et al. FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. J. Antibiot. 43, 1\u20137 (1990).","journal-title":"J. Antibiot."},{"key":"BFja2016106_CR10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.7164\/antibiotics.47.1092","volume":"47","author":"T Iwamoto","year":"1994","unstructured":"Iwamoto, T. et al. WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties. J. Antibiot. 47, 1092\u20131097 (1994).","journal-title":"J. Antibiot."},{"key":"BFja2016106_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1128\/AAC.48.3.774-779.2004","volume":"48","author":"H Hamamoto","year":"2004","unstructured":"Hamamoto, H. et al. Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms. Antimicrob. Agents Chemother. 48, 774\u2013779 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2016106_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nchembio.1710","volume":"11","author":"H Hamamoto","year":"2015","unstructured":"Hamamoto, H. et al. Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat. Chem. Biol. 11, 127\u2013133 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"BFja2016106_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/mpat.2002.0494","volume":"32","author":"C Kaito","year":"2002","unstructured":"Kaito, C., Akimitsu, N., Watanabe, H. & Sekimizu, K. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb. Pathog. 32, 183\u2013190 (2002).","journal-title":"Microb. Pathog."},{"issue":"1","key":"BFja2016106_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ja.2016.107","volume":"70","author":"Ikuko Nakamura","year":"2016","unstructured":"Nakamura, I. et al. ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-34783. J. Antibiot. (e-pub ahead of print; doi:10.1038\/ja.2016.107).","journal-title":"The Journal of Antibiotics"},{"key":"BFja2016106_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1348-0421.2008.00053.x","volume":"52","author":"K Maki","year":"2008","unstructured":"Maki, K. et al. Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds. Microb. Immunol. 52, 383\u2013391 (2008).","journal-title":"Microb. Immunol."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja2016106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2016106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2016106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T21:10:44Z","timestamp":1640985044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja2016106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFja2016106"],"URL":"https:\/\/doi.org\/10.1038\/ja.2016.106","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]},"assertion":[{"value":"5 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}